An overview of the long-term care situation in Belgium is available here.

An overview of the long-term care situation in Norway is available here.

An overview of the long-term care situation in Israel is available here.

An overview of the long-term care situation in Canada is available here.

An overview of the long-term care situation in Poland is available here.

An overview of the long-term care situation in Slovenia is available here.

An overview of the long-term care situation in Hungary is available here.

An overview of the long-term care situation in New Zealand is available here.

An overview of the long-term care situation in the United Kingdom is available here.

An overview of the long-term care situation in the Netherlands is available here.

An overview of the long-term care situation in Mexico is available here.

An overview of the long-term care situation in Germany is available here.

An overview of the long-term care situation in the Czech Republic is available here.

An overview of the long-term care situation in Switzerland is available here.

An overview of the long-term care situation in Sweden is available here.

An overview of the long-term care situation in Spain is available here.

An overview of the long-term care situation in Finland is available here.

An overview of the long-term care situation in Australia is available here.

An overview of the long-term care situation in Greece is available here.

An overview of the long-term care situation in Ireland is available here.

Health spending continues to rise faster than economic growth in most OECD countries, maintaining a trend observed since the 1970s. Health spending reached 9.5% of GDP on average in 2009, the most recent year for which figures are available, up from 8.8% in 2008, according to OECD Health Data 2011.

This book examines international drivers, enabling technologies fast-tracking industrial biotechnology, industry trends, some products appearing on the market, industry structure and finance, and policy measures and trends. It examines separately biofuels, biobased chemicals and bioplastics.

The Swiss health system is one of the world’s best but must adapt to deal with rising costs and higher rates of cancer, cardiovascular disease and diabetes, according to a new OECD/WHO report.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

Though overall medical care is improving, efforts to prevent and better manage chronic diseases such as diabetes and asthma would improve results and lower costs, according to the OECD’s latest edition of Health at a Glance.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

The OECD’s latest edition of Health at a Glance shows that medical care is improving in OECD countries, but better prevention and management of chronic diseases is required to reduce costs.

Mental illness is a growing problem in society and is increasingly affecting productivity and well-being in the workplace, according to a new OECD report.

More people in developed countries are overweight or obese than ever before, dooming them to years of ill-health and early death. New OECD data show however that in some countries obesity rates are slowing, and that’s good news for people’s health and government budgets.

Across OECD countries some 83 million people suffer from diabetes. On current trends, that will rise to almost 100 million by 2030.

This book introduces the concept of knowledge networks and markets (KNMs) in the life sciences, the emerging organisations and mechanisms to share and trade an increasing variety of knowledge assets.

Data from OECD Health Data 2012 focusing on key US issues: why is the US health spending so high? Is US health spending higher due to higher prices or higher service provision? (or both?)? Is the quality of care better in the US? What are the trends in key risk factors to health in the US?

한국의 GDP 대비 국민의료비 비중은 2000년 4.5% 에서 2010년 처음으로 7%을 넘은 것(7.1%)으로 나타났다. 그러나 한국의 GDP 대비 국민의료비 비중 7.1%는 OECD 평균 9.5 %에 비해서는 낮은 편이다. 미국은 GDP 대비 17.6%로 가장 높다.

Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term trend of rapid increases, according to OECD Health Data 2012.

The obesity epidemic slowed down in several OECD countries during the past three years. Rates grew less that previously projected, or did not grow at all, according to new data from ten OECD countries. However, rates remain high and social disparities in obesity are unabated.

Israel has world class-primary care services and should now focus efforts on bringing its hospitals up to the same high international standards, according to the OECD’s Health Care Quality Review of Israel.

The OECD and the ESRC Genomics Policy & Research Forum jointly organised a one-day Forum on 12 November 2012 in Paris. The event was both retrospective and forward-looking. The forum concluded that the promise of biotechnology is not set but evolves with fresh scientific knowledge, novel laws and regulations. The future of biotechnology needs to also integrate social and cultural dimensions.

New OECD data show that men are more likely to be admitted to hospital as a result of poor management of diabetes than women, even when there are no significant differences in the number of men and women living with diabetes.

This workshop will convene leading experts from health and finance backgrounds in government, academia, and international organisations to take stock of progress in health expenditure forecasting and to discuss future directions, in light of policy needs and recent advancements in techniques, detailed data and computing power.

Health spending fell across the European Union in 2010, as cash-strapped governments curbed outlays to help cut budgetary deficits, according to Health at a Glance: Europe 2012, a new joint report by the OECD and the European Commission.

Though the rate of public spending on healthcare in the Asia/Pacific region is still well below the OECD average, countries there are committing more resources to improving health care quality.

The Netherlands, as other OECD countries, faces the challenge of providing high quality health and long term care services to an ageing population in a cost-efficient manner.

Belgian companies, mutualities and employment services should be more proactive in helping people with mental health problems stay in the workplace or find a job, according to a new OECD report.

OECD Health Working Papers No. 60: Health Spending Growth at Zero: Which Countries, Which Sectors Are Most Affected?

Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leading to a decline in the number of international trials conducted by academics for non-commerical purposes.